Cargando…
Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome
The objective of this study was to analyse levels of the proinflammatory cytokine macrophage migration inhibitory factor (MIF) in patients with primary Sjögren's syndrome (pSS) and to examine associations of MIF with clinical, serological and immunological variables. MIF was determined by ELISA...
Autores principales: | Willeke, Peter, Gaubitz, Markus, Schotte, Heiko, Maaser, Christian, Domschke, Wolfram, Schlüter, Bernhard, Becker, Heidemarie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906791/ https://www.ncbi.nlm.nih.gov/pubmed/17470266 http://dx.doi.org/10.1186/ar2182 |
Ejemplares similares
-
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
por: Willeke, Peter, et al.
Publicado: (2007) -
Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis
por: Schotte, Heiko, et al.
Publicado: (2015) -
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
por: Kanemitsu, Hirohito, et al.
Publicado: (2009) -
Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis
por: Willeke, P., et al.
Publicado: (2015) -
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis
por: Grygorczuk, Sambor, et al.
Publicado: (2017)